(Q28258045)

English

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study (English)

0 references

main subject

phase II clinical trial

0 references

1 reference

1 reference

1 reference

3

Bradley J Monk

0 references

author name string

Robert A Burger

series ordinal

1

0 references

Michael W Sill

series ordinal

2

0 references

Benjamin E Greer

series ordinal

4

0 references

Joel I Sorosky

series ordinal

5

0 references

language of work or name

English

0 references

publication date

20 November 2007

0 references

published in

Journal of Clinical Oncology

0 references

volume

25

0 references

issue

33

0 references

page(s)

5165-71

0 references

Identifiers

DOI

10.1200/JCO.2007.11.5345

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1733820

OpenCitations bibliographic resource ID

1733820

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1733820

PubMed publication ID

18024863

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1733820

(Q28258045)

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)